SHKK(SH:600272) Xin Lang Cai Jing·2026-01-05 02:32Core Viewpoint - The stock of Kaikai Industrial has shown a mixed performance, with a slight increase of 2.05% year-to-date, but a significant decline of 22.20% over the past 20 days, indicating volatility in its market performance [1]. Financial Performance - For the period from January to September 2025, Kaikai Industrial reported a revenue of 825 million yuan, reflecting a year-on-year growth of 10.76%. However, the net profit attributable to shareholders decreased by 62.81% to 12.87 million yuan [2]. - Cumulative cash dividends since the company's A-share listing amount to 191 million yuan, with 34.75 million yuan distributed over the past three years [3]. Shareholder Structure - As of September 30, 2025, the number of shareholders for Kaikai Industrial is 33,700, which represents a decrease of 7.03% compared to the previous period. The average circulating shares per person remain at 0 [2]. - Among the top ten circulating shareholders, China Merchants Securities (Hong Kong) Co., Ltd. holds 1.13 million shares, unchanged from the previous period. BOCI Securities Limited holds 862,700 shares, also unchanged, while the China Securities Shanghai State-owned Enterprise ETF has reduced its holdings by 164,200 shares to 787,500 shares [3]. Business Overview - Kaikai Industrial, established on August 4, 1997, and listed on February 28, 2001, operates primarily in the fields of traditional Chinese medicine distribution, Chinese medicine services, and clothing wholesale and retail. The revenue composition is as follows: wholesale 74.48%, retail 18.18%, health services 4.42%, leasing 1.77%, and others 1.14% [1]. - The company is classified under the pharmaceutical and biological industry, specifically in pharmaceutical commerce and distribution, and is associated with concepts such as pharmaceutical e-commerce, traditional Chinese medicine, and biopharmaceuticals [1].